Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color PatientsRecruiting
NCT06447480Phase 3Updated May 20, 2026
Sponsor: Centre Hospitalier Universitaire de Nice
Acne Vulgaris
France, French Guiana
A Long-term Extension Clinical Study of TLL-018 in Patients With Rheumatoid ArthritisRecruiting
NCT06887127Phase 3Updated May 20, 2026
Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd
Rheumatoid Arthritis
China
Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHNRecruiting
NCT07264075Phase 3Updated May 20, 2026
Sponsor: Groupe Oncologie Radiotherapie Tete et Cou
Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)
France
Efficacy of Gou-Teng-San (GTS) in Patients With Episodic MigraineRecruiting
NCT07496034Phase 3Updated May 20, 2026
Sponsor: Tsai, Chueh-Yi, MD
Episodic Migraine
Taiwan
A Study of Intra-operative Imaging in Women With Ovarian CancerRecruiting
NCT04878094Phase 3Updated May 20, 2026
Sponsor: Memorial Sloan Kettering Cancer Center
Ovarian Cancer · Ovarian Carcinoma
United States
Quality of Life After Billroth II or Roux-en-Y for Gastric CancerRecruiting
NCT06768164Phase 3Updated May 20, 2026
Sponsor: Assistance Publique - Hôpitaux de Paris
Gastric (Cardia, Body) Cancer
France
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)Recruiting
NCT06911502Phase 3Updated May 20, 2026
Sponsor: Celgene
Follicular Lymphoma
United States, Australia, Brazil, Canada, Chile +16 more
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)Recruiting
NCT06651281Phase 3Updated May 19, 2026
Sponsor: Merck Sharp & Dohme LLC
Crohn Disease · Colitis, Ulcerative
United States, Czechia, France, Georgia, Hungary +2 more
Understanding and Treating Suicidal Ideation With KetamineRecruiting
NCT06891300Phase 2, Phase 3Updated May 19, 2026
Sponsor: The Royal's Institute of Mental Health Research
Suicidal Ideation · Major Depressive Disorder (MDD)
Canada
Effect of Remimazolam Sedation on Outcomes of Mechanically Ventilated Patients in the ICURecruiting
NCT07596589Phase 3Updated May 19, 2026
Sponsor: Southeast University, China
Remimazolam Besylate · Mechanically Ventilated ICU Patients · Sedation
China
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)Recruiting
NCT05183035Phase 3Updated May 19, 2026
Sponsor: PedAL BCU, LLC
Acute Myeloid Leukemia
United States, Australia, Austria, Belgium, Canada +15 more
Personalized Medicine for Advanced Biliary Cancer PatientsRecruiting
NCT05615818Phase 3Updated May 19, 2026
Sponsor: UNICANCER
Biliary Tract Neoplasms
Belgium, France, United Kingdom
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 InhibitorRecruiting
NCT04966481Phase 3Updated May 19, 2026
Sponsor: Washington University School of Medicine
HPV-unrelated Head and Neck Squamous Cell Carcinoma
United States
An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.Recruiting
NCT05884255Phase 3Updated May 19, 2026
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Advanced Gastroenteropancreatic Neuroendocrine Tumor
China
The SELEQT-HF (SELEnium and CoQ10 NuTrition for Heart Failure) Study Will Evaluate the Effect of Adding Selenium/and coQ10 on Top of Standard HF Therapy in Patients With HF and Will do so Using a Pragmatic, Registry Based Randomized Controlled Trial in the Netherlands.Recruiting
NCT07234422Phase 3Updated May 19, 2026
Sponsor: Netherlands Heart Institute
Heart Failure
Netherlands
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)Recruiting
NCT07154706Phase 3Updated May 19, 2026
Sponsor: Nuvation Bio Inc.
Non-small Cell Lung Cancer (NSCLC)
United States, Canada, China
Efficacy, Safety, and Tolerability of 4-MUST, 128 mg Tablets in Chronic Cholecystitis and Biliary DyskinesiaRecruiting
NCT07595003Phase 3Updated May 19, 2026
Sponsor: Valenta Pharm JSC
Chronic Cholecystitis · Biliary Dyskinesia
Russia
Bedaquiline Enhanced Post ExpOsure Prophylaxis for LeprosyRecruiting
NCT05597280Phase 3Updated May 19, 2026
Sponsor: Institute of Tropical Medicine, Belgium
Leprosy
Comoros
Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use DisorderRecruiting
NCT05011266Phase 2, Phase 3Updated May 19, 2026
Sponsor: New York State Psychiatric Institute
Opioid-use Disorder
United States
Ventilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation TherapyRecruiting
NCT06127654Phase 3Updated May 19, 2026
Sponsor: University of Sydney
Lung Cancer
Australia
PROGAIN Trial in Gastric Cancer SurgeryRecruiting
NCT07488611Phase 3Updated May 19, 2026
Sponsor: Soonchunhyang University Hospital
Stomach (Gastric) Cancer
South Korea
Spironolactone Improved Children With Gene Mutations Related to NCORRecruiting
NCT06678685Phase 2, Phase 3Updated May 18, 2026
Sponsor: Qilu Hospital of Shandong University
NCOR Gene Mutations · Spironolactone · ASD
China
INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell CarcinomaRecruiting
NCT07002346Phase 3Updated May 18, 2026
Sponsor: Tongji Hospital
Ovarian Clear Cell Carcinoma
China
A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients With POS 2 to 17 Year OldsRecruiting
NCT07594158Phase 3Updated May 18, 2026
Sponsor: Ono Pharmaceutical Co., Ltd.
Partial Epilepsy
Japan
Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent StrokeRecruiting
NCT05892510Phase 2, Phase 3Updated May 18, 2026
Sponsor: University of Melbourne
Ischemic Stroke, Acute · Cerebrovascular Disorders · Brain Disorder · Central Nervous System Diseases
Australia, New Zealand

Previous page Next page